Trial Profile
Fukuoka study of ipraglifrozin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Feb 2019
Price :
$35
*
At a glance
- Drugs Ipragliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Acronyms FUSION
- 02 Mar 2018 Status changed from active, no longer recruiting to completed.
- 12 Aug 2014 New trial record